Early Changes of Irradiated Parotid Glands Evaluated by T1rho-Weighted Imaging: A Pilot Study
Overview
Authors
Affiliations
Objective: The aim of the study was to confirm the feasibility of T1rho-weighted imaging to evaluate the dynamic changes of parotid glands in patients with nasopharyngeal carcinoma (NPC) undergoing intensity-modulated radiation therapy.
Methods: Twenty-six NPC patients (19 men; 7 women; mean [SD] age, 48.9 [13.4] years) underwent the following 3 serial T1rho-weighted imaging: within 2 weeks before radiotherapy (RT, pre-RT), 5 weeks after the beginning of RT (mid-RT), and 4 weeks after RT (post-RT). Parotid volumes, T1rho values, mean radiation doses, and xerostomia degrees were recorded. Change rates of parotid T1rho values were correlated with parotid atrophy rates, mean radiation doses, and xerostomia degrees.
Results: During RT, parotid volume decreased (atrophy rate, 32.7 [8.1%] at mid-RT and 27.9 [10.0%] at post-RT compared with pre-RT; both P < 0.001) and parotid T1rho values increased (change rate, 25.0 [15.8%] at mid-RT and 30.1 [18.0%] at post-RT compared with pre-RT, both P < 0.001) significantly. The change rate of parotid T1rho value correlated with the atrophy rate significantly at post-RT (r = 0.301, P = 0.047). Intraobserver and interobserver reproducibility of parotid T1rho measurements were excellent (intraclass correlation coefficient, 0.974 and 0.956, respectively).
Conclusions: Dynamic changes of radiation-induced parotid damage in NPC patients who underwent intensity-modulated radiation therapy could be noninvasively evaluated by T1rho-weighted imaging.
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance.
McDonald B, Dal Bello R, Fuller C, Balermpas P Semin Radiat Oncol. 2023; 34(1):69-83.
PMID: 38105096 PMC: 11372437. DOI: 10.1016/j.semradonc.2023.10.003.
MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers.
Mulder S, Heukelom J, McDonald B, van Dijk L, Wahid K, Sanders K Cancers (Basel). 2022; 14(8).
PMID: 35454816 PMC: 9028510. DOI: 10.3390/cancers14081909.
T for Radiotherapy Treatment Response Monitoring in Rectal Cancer Patients: A Pilot Study.
Kooreman E, Tanaka M, Ter Beek L, Peters F, Marijnen C, van der Heide U J Clin Med. 2022; 11(7).
PMID: 35407606 PMC: 8999631. DOI: 10.3390/jcm11071998.
Feasibility of DW-MRI analysis of salivary glands during head and neck radiotherapy.
Duffton A, Kemp O, Devlin L, Hay L, McLoone P, Paterson C Tech Innov Patient Support Radiat Oncol. 2021; 19:46-51.
PMID: 34527819 PMC: 8430428. DOI: 10.1016/j.tipsro.2021.07.002.
Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy.
Wang C, Padgett K, Su M, Mellon E, Maziero D, Chang Z Med Phys. 2021; 49(4):2794-2819.
PMID: 34374098 PMC: 9769892. DOI: 10.1002/mp.15130.